CAMBRIDGE, England--(BUSINESS WIRE)--Abselion, a pioneering life sciences technology company focused on simplifying biomolecule quantification, has expanded its Amperia™ assay portfolio with the ...
Nomic Publishes Foundational Protein Quantification Technology in Nature Methods The company highlights how its technology powers large-scale proteomic perturbation studies, unveiling Perturb-PBMC, a ...
New kit enables rapid, accurate titre measurement across broad range of IgG subclasses and species on Amperia platform Abselion, a pioneering life sciences technology company focused on simplifying ...
Abselion, a life sciences tech company anchored in Cambridge UK and focused on simplifying biomolecule quantification, has ...
Protein detection sensitivity has historically lagged behind nucleic acid detection by 2-3 orders of magnitude due to the lack of intrinsic signal amplification. While digital methods such as Single ...
News-Medical.Net on MSN
Abselion establishes US subsidiary in Cambridge, MA
Abselion, a pioneering life sciences technology company focused on simplifying biomolecule quantification, today announced that it has established a US subsidiary at The Engine in Cambridge, MA. The ...
One of the hardest things to do when you establish an experiment that requires the measurement of proteins, cytokines, or biomarkers is the selection of the appropriate assay kit. Product catalogs are ...
Proteomics technologies are expanding rapidly due to advances in mass spectrometry, AI-driven analysis, and single-cell approaches. Growing investment and new applications in drug discovery and ...
Abselion, a pioneering life sciences technology company focused on simplifying biomolecule quantification, today announced the launch of its Protein G Total Antibody Quantification Kit. The new kit is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results